Market Whales and Their Recent Bets on VKTX Options
Market Whales and Their Recent Bets on VKTX Options
Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics (NASDAQ:VKTX).
有大量资金可以花的投资者对Viking Therapeutics（纳斯达克股票代码：VKTX）采取了看跌立场。
And retail traders should know.
零售交易者应该知道。
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
今天，当我们在本辛加追踪的公开期权历史记录中出现头寸时，我们注意到了这一点。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VKTX, it often means somebody knows something is about to happen.
无论这些是机构还是仅仅是富人，我们都不知道。但是，当 VKTX 发生这么大的事情时，通常意味着有人知道某件事即将发生。
Today, Benzinga's options scanner spotted 10 options trades for Viking Therapeutics.
今天，Benzinga的期权扫描仪发现了Viking Therapeutics的10笔期权交易。
This isn't normal.
这不正常。
The overall sentiment of these big-money traders is split between 20% bullish and 80%, bearish.
这些大额交易者的整体情绪分为20％看涨和80％（看跌）。
Out of all of the options we uncovered, there was 1 put, for a total amount of $63,900, and 9, calls, for a total amount of $718,259.
在我们发现的所有期权中，有1个看跌期权，总额为63,900美元，还有9个看涨期权，总额为718,259美元。
What's The Price Target?
目标价格是多少？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $55.0 to $90.0 for Viking Therapeutics during the past quarter.
通过分析这些合约的交易量和未平仓合约，大型企业似乎一直在考虑在过去一个季度中将Viking Therapeutics的价格范围从55.0美元到90.0美元不等。
Volume & Open Interest Development
交易量和未平仓合约的发展
In today's trading context, the average open interest for options of Viking Therapeutics stands at 1655.67, with a total volume reaching 2,742.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Viking Therapeutics, situated within the strike price corridor from $55.0 to $90.0, throughout the last 30 days.
在今天的交易背景下，维京疗法期权的平均未平仓合约为1655.67份，总成交量达到2742.00。随附的图表描绘了过去30天Viking Therapeutics高价值交易的看涨期权和看跌期权交易量以及未平仓合约的变化，行使价走势从55.0美元到90.0美元不等。
Viking Therapeutics Option Activity Analysis: Last 30 Days
Viking Therapeutics 期权活动分析：过去 30 天
Noteworthy Options Activity:
值得注意的期权活动：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BULLISH | 05/17/24 | $3.1 | $2.9 | $3.1 | $75.00 | $310.0K | 2.2K | 10 |
| VKTX | CALL | SWEEP | BEARISH | 04/19/24 | $10.8 | $10.2 | $10.2 | $55.00 | $106.0K | 4.7K | 242 |
| VKTX | CALL | TRADE | NEUTRAL | 05/17/24 | $3.1 | $2.9 | $3.0 | $75.00 | $75.0K | 2.2K | 1.0K |
| VKTX | CALL | TRADE | BEARISH | 04/19/24 | $11.3 | $10.1 | $10.3 | $55.00 | $69.0K | 4.7K | 112 |
| VKTX | PUT | SWEEP | BEARISH | 04/19/24 | $1.0 | $0.75 | $1.0 | $65.00 | $63.9K | 1.8K | 699 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 打电话 | 贸易 | 看涨 | 05/17/24 | 3.1 美元 | 2.9 美元 | 3.1 美元 | 75.00 美元 | 310.0 万美元 | 2.2K | 10 |
| VKTX | 打电话 | 扫 | 粗鲁的 | 04/19/24 | 10.8 美元 | 10.2 美元 | 10.2 美元 | 55.00 美元 | 106.0 万美元 | 4.7K | 242 |
| VKTX | 打电话 | 贸易 | 中立 | 05/17/24 | 3.1 美元 | 2.9 美元 | 3.0 美元 | 75.00 美元 | 75.0 万美元 | 2.2K | 1.0K |
| VKTX | 打电话 | 贸易 | 粗鲁的 | 04/19/24 | 11.3 美元 | 10.1 | 10.3 美元 | 55.00 美元 | 69.0 万美元 | 4.7K | 112 |
| VKTX | 放 | 扫 | 粗鲁的 | 04/19/24 | 1.0 美元 | 0.75 美元 | 1.0 美元 | 65.00 美元 | 63.9 万美元 | 1.8K | 699 |
About Viking Therapeutics
关于维京疗法
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家医疗保健服务提供商。该公司专门从事以代谢和内分泌失调为重点的生物药品开发领域。该公司的临床项目管道包括 VK2809、VK5211、VK0214 产品。VK2809 和 VK0214 是可口服的甲状腺激素受体 β 的组织和受体亚型选择性激动剂。VK5211 是一种口服的非甾体选择性雄激素受体调节剂。
Where Is Viking Therapeutics Standing Right Now?
Viking Therapeutics 现在处于什么位置？
- Trading volume stands at 800,529, with VKTX's price down by -1.64%, positioned at $65.38.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 6 days.
- 交易量为800,529美元，其中VKTX的价格下跌了-1.64％，为65.38美元。
- RSI指标显示，该股目前在超买和超卖之间处于中立状态。
- 预计将在6天后公布财报。
What The Experts Say On Viking Therapeutics
专家对维京疗法的看法
In the last month, 4 experts released ratings on this stock with an average target price of $122.75.
上个月，4位专家发布了该股的评级，平均目标价为122.75美元。
- In a cautious move, an analyst from HC Wainwright & Co. downgraded its rating to Buy, setting a price target of $90.
- An analyst from Oppenheimer has decided to maintain their Outperform rating on Viking Therapeutics, which currently sits at a price target of $138.
- An analyst from Oppenheimer has decided to maintain their Outperform rating on Viking Therapeutics, which currently sits at a price target of $138.
- Maintaining their stance, an analyst from BTIG continues to hold a Buy rating for Viking Therapeutics, targeting a price of $125.
- HC Wainwright & Co. 的一位分析师谨慎地将其评级下调至买入，将目标股价定为90美元。
- 奥本海默的一位分析师已决定维持对Viking Therapeutics的跑赢大盘评级，该评级目前的目标股价为138美元。
- 奥本海默的一位分析师已决定维持对Viking Therapeutics的跑赢大盘评级，该评级目前的目标股价为138美元。
- BTIG的一位分析师坚持其立场，继续维持对Viking Therapeutics的买入评级，目标价格为125美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比，期权是一种风险更高的资产，但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。